CO6190540A2 - Compuesto ceramico polimero y metodo - Google Patents
Compuesto ceramico polimero y metodoInfo
- Publication number
- CO6190540A2 CO6190540A2 CO09054994A CO09054994A CO6190540A2 CO 6190540 A2 CO6190540 A2 CO 6190540A2 CO 09054994 A CO09054994 A CO 09054994A CO 09054994 A CO09054994 A CO 09054994A CO 6190540 A2 CO6190540 A2 CO 6190540A2
- Authority
- CO
- Colombia
- Prior art keywords
- composite material
- polymer phase
- poly
- copolymer
- alpha
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 8
- 239000000919 ceramic Substances 0.000 title abstract 3
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 239000002131 composite material Substances 0.000 abstract 9
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 abstract 4
- 229920001577 copolymer Polymers 0.000 abstract 4
- 229920001610 polycaprolactone Polymers 0.000 abstract 3
- 239000004632 polycaprolactone Substances 0.000 abstract 3
- 239000007787 solid Substances 0.000 abstract 3
- 239000002904 solvent Substances 0.000 abstract 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 abstract 2
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 abstract 2
- 229910000389 calcium phosphate Inorganic materials 0.000 abstract 2
- 239000001506 calcium phosphate Substances 0.000 abstract 2
- 235000011010 calcium phosphates Nutrition 0.000 abstract 2
- 239000000463 material Substances 0.000 abstract 2
- 229920000747 poly(lactic acid) Polymers 0.000 abstract 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 abstract 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 1
- 239000002202 Polyethylene glycol Substances 0.000 abstract 1
- 229920000954 Polyglycolide Polymers 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- -1 hydroxy esters Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000006069 physical mixture Substances 0.000 abstract 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 abstract 1
- 229920001223 polyethylene glycol Polymers 0.000 abstract 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 abstract 1
- 238000007711 solidification Methods 0.000 abstract 1
- 230000008023 solidification Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/446—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with other specific inorganic fillers other than those covered by A61L27/443 or A61L27/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/12—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J3/00—Processes of treating or compounding macromolecular substances
- C08J3/20—Compounding polymers with additives, e.g. colouring
- C08J3/205—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase
- C08J3/21—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase
- C08J3/212—Compounding polymers with additives, e.g. colouring in the presence of a continuous liquid phase the polymer being premixed with a liquid phase and solid additives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/01—Use of inorganic substances as compounding ingredients characterized by their specific function
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
- C08J2367/04—Polyesters derived from hydroxy carboxylic acids, e.g. lactones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Materials For Medical Uses (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Biological Depolymerization Polymers (AREA)
- Prostheses (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Curing Cements, Concrete, And Artificial Stone (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US85590406P | 2006-10-31 | 2006-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO6190540A2 true CO6190540A2 (es) | 2010-08-19 |
Family
ID=39344908
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO09054994A CO6190540A2 (es) | 2006-10-31 | 2009-05-28 | Compuesto ceramico polimero y metodo |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20100041770A1 (https=) |
| EP (1) | EP2086604A2 (https=) |
| JP (1) | JP2010508071A (https=) |
| KR (1) | KR20090091710A (https=) |
| CN (1) | CN101600462A (https=) |
| AU (1) | AU2007314268A1 (https=) |
| BR (1) | BRPI0718068A2 (https=) |
| CA (1) | CA2668265A1 (https=) |
| CO (1) | CO6190540A2 (https=) |
| WO (1) | WO2008054794A2 (https=) |
| ZA (1) | ZA200903689B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1112095E (pt) | 1998-09-11 | 2003-04-30 | Axel Stemberger | Implantes biologicamente activos |
| US20100226956A1 (en) * | 2009-03-06 | 2010-09-09 | Per Kjellin | Production of moldable bone substitute |
| CN102858278B (zh) * | 2010-04-29 | 2016-08-17 | 华沙整形外科股份有限公司 | 可流动陶瓷胶泥 |
| NL2011195C2 (en) | 2013-07-18 | 2015-01-21 | Xpand Biotechnology B V | Method for producing an osteoinductive calcium phosphate and products thus obtained. |
| US10682442B2 (en) | 2014-04-04 | 2020-06-16 | University Of Kentucky Research Foundation | Small molecule drug release from in situ forming degradable scaffolds incorporating hydrogels and bioceramic microparticles |
| JP6663608B2 (ja) * | 2014-09-01 | 2020-03-13 | 国立大学法人九州大学 | 骨欠損再建治療用キット、医療用硬組織再建材、製品無機化合物の製造方法及び製品無機化合物 |
| WO2016140626A1 (en) * | 2015-03-04 | 2016-09-09 | Agency For Science, Technology And Research | Composite material for drug delivery |
| EP3954402A4 (en) * | 2019-08-31 | 2023-01-11 | Shenzhen Corliber Scientific Co., Ltd. | PLASTIC ARTIFICIAL BONE COMPOSITE MATERIAL AND PROCESS FOR ITS PRODUCTION |
| CN111110929B (zh) * | 2020-02-15 | 2020-12-22 | 深圳脉动医学技术有限公司 | 一种高生物安全性心脏支架及其制造方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6926903B2 (en) * | 2001-12-04 | 2005-08-09 | Inion Ltd. | Resorbable polymer composition, implant and method of making implant |
| GB0302026D0 (en) * | 2003-01-29 | 2003-02-26 | Biocomposites Ltd | Bioabsorbable implant |
| EP1594423B1 (en) * | 2003-02-14 | 2009-01-07 | DePuy Spine, Inc. | In-situ formed intervertebral fusion device |
| EP1778760A4 (en) * | 2004-07-30 | 2009-01-21 | Univ Nebraska | BIOREGRADABLE COMPOSITES AND METHOD FOR FORMING THE SAME |
-
2007
- 2007-10-31 WO PCT/US2007/023014 patent/WO2008054794A2/en not_active Ceased
- 2007-10-31 JP JP2009534709A patent/JP2010508071A/ja not_active Withdrawn
- 2007-10-31 AU AU2007314268A patent/AU2007314268A1/en not_active Abandoned
- 2007-10-31 BR BRPI0718068-3A2A patent/BRPI0718068A2/pt not_active IP Right Cessation
- 2007-10-31 KR KR1020097009947A patent/KR20090091710A/ko not_active Withdrawn
- 2007-10-31 CA CA002668265A patent/CA2668265A1/en not_active Abandoned
- 2007-10-31 CN CNA2007800445770A patent/CN101600462A/zh active Pending
- 2007-10-31 EP EP07867330A patent/EP2086604A2/en not_active Withdrawn
- 2007-10-31 US US12/447,959 patent/US20100041770A1/en not_active Abandoned
-
2009
- 2009-05-27 ZA ZA200903689A patent/ZA200903689B/xx unknown
- 2009-05-28 CO CO09054994A patent/CO6190540A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP2086604A2 (en) | 2009-08-12 |
| CN101600462A (zh) | 2009-12-09 |
| KR20090091710A (ko) | 2009-08-28 |
| WO2008054794A3 (en) | 2008-09-18 |
| AU2007314268A1 (en) | 2008-05-08 |
| CA2668265A1 (en) | 2008-05-08 |
| WO2008054794A2 (en) | 2008-05-08 |
| BRPI0718068A2 (pt) | 2013-10-29 |
| ZA200903689B (en) | 2010-08-25 |
| JP2010508071A (ja) | 2010-03-18 |
| US20100041770A1 (en) | 2010-02-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO6190540A2 (es) | Compuesto ceramico polimero y metodo | |
| WO2007084460A3 (en) | Pharmaceutical compositions with enhanced stability | |
| ES2524320T3 (es) | Composición para la prevención o el tratamiento de enfermedad asociada con trombo o émbolo | |
| WO2008122966A3 (en) | A pharmaceutical composition of tacrolimus | |
| CY1121316T1 (el) | Λειτουργια δινης για συστημα χορηγησης φαρμακευτικης ουσιας | |
| BR112012032581A2 (pt) | filme e adesivo que bloquea oxigênio | |
| ES2557988T3 (es) | Método para tratar enfermedades de próstata basado en el suministro local de principios activos | |
| FI3360538T3 (fi) | Injektoitava, juokseva koostumus käsittäen buprenorfiinia | |
| RU2014116247A (ru) | Медицинские устройства, содержащие полимерные композиции с памятью формы | |
| NZ604342A (en) | Antipsychotic injectable depot composition | |
| CL2003002277A1 (es) | Composicion farmaceutica inyectable, de deposito de liberacion prolongada, que comprende un agente beneficioso disuelto o disperso en un gel constituido por un polimero bioerosionable y biocompatible; y un solvente. | |
| US8834915B2 (en) | Drug-containing bioabsorbable fibers and implants | |
| BRPI0816076B8 (pt) | Filme de barreira de oxigênio ativa multicamada e embalagem | |
| DE69914787D1 (de) | Flüssige zusammensetzungen mit kontrollierter freigabe mit niedrigem initialfreisetzungsstoss des wirkstoffs | |
| MX2009010907A (es) | Formulacion del agente activo cargado en nanoparticulas de plga activadas para nano-terapeuticos direccionados para el cancer. | |
| PE20060244A1 (es) | Formulacion farmaceutica de deposito que contiene polietilenglicol de peso molecular menor a 600 daltones | |
| WO2008054772A3 (en) | Implantable elastomeric caprolactone depot compositions and uses thereof | |
| PE20041065A1 (es) | Composiciones farmaceuticas que comprenden ester de testosterona y aceite de ricino | |
| SA520412229B1 (ar) | تركيبات صيدلية لها فترة إطلاق مُختارة | |
| MX359119B (es) | Formulaciones de liberación sostenida para el suministro de proteínas al ojo y métodos para prepararlas. | |
| PE20030519A1 (es) | Forma de dosificacion, dispositivo y metodos de tratamiento | |
| AR053968A1 (es) | Composiciones de polimeros antimicrobianas de liberacion controlada | |
| ECSP11011001A (es) | Composición farmacéutica sólida | |
| JP2010508071A5 (https=) | ||
| CL2008001509A1 (es) | Composicion farmaceutica de liberacion prolongada que comprende micro-particulas con una matriz que comprende un polimero polilactido-co-glicolido lineal y uno ramificado y pamoato de pasireotida; proceso de elaboracion; micro-particulas; kit; uso para tratar una enfermedad asociada con un exceso de secrecion de gh y/o igf-1. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Application withdrawn |